What is the target price for Altamira Therapeutics stock?

Forecast target price for 06-18-2023: $ 0.86. Positive dynamics for Altamira Therapeutics shares will prevail with possible volatility of 4.216%. Altamira Therapeutics Stock Forecast 06-19-2023. Forecast target price for 06-19-2023: $ 0.85. Negative dynamics for Altamira Therapeutics shares will prevail with possible volatility of 4.613%.

Who owns Altamira Therapeutics (ears)?

Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda. Real time Altamira Therapeutics (EARS) stock price quote, stock graph, news & analysis.

Who owns Altamira?

Altamira is a privately-owned company. TA Associates of Boston owns 39 per cent of the company, 33 per cent is held by Altamira insiders, and 28 per cent is held by institutional investors. Reports have said TA has wanted to sell its Altamira stake which it acquired in 1997 for some time.

The World's Leading Crypto Trading Platform

Get my welcome gifts